3.60
2.96%
-0.11
Handel nachbörslich:
3.60
Finanzdaten der Vaccinex Inc-Aktie (VCNX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
0.104
|
- | 0.02 | - | 0.55 |
Operating Expenses
|
3.81%
5.178
|
4.988 | 5.854 | 7.077 | 5.536 |
Benefits Costs and Expenses |
20.62%
4.001
|
3.317 | 4.932 | 7.06 | 5.512 |
Costs And Expenses |
3.81%
5.178
|
4.988 | 5.854 | 7.077 | 5.536 |
Operating Income/Loss |
1.72%
-5.074
|
-4.988 | -5.834 | -7.077 | -4.986 |
Income/Loss From Continuing Operations Before Tax |
17.49%
-3.897
|
-3.317 | -4.912 | -7.06 | -4.962 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
17.49%
-3.897
|
-3.317 | -4.912 | -7.06 | -4.962 |
Net Income/Loss
|
17.49%
-3.897
|
-3.317 | -4.912 | -7.06 | -4.962 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
138.03%
1.3273
|
-3.4898 | 4.5068 | 60.42 | 49.88 |
Diluted Average Shares |
138.03%
1.3273
|
-3.4898 | 4.5068 | 60.42 | 49.88 |
Basic Earnings Per Share |
92.54%
-2.94
|
-39.40 | -1.09 | -0.12 | -0.10 |
Diluted Earnings Per Share |
92.54%
-2.94
|
-39.40 | -1.09 | -0.12 | -0.10 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):